Kronos Bio Inc.
(KRON)
undefined
undefined%
At close: undefined
0.98
0.51%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -112.67M | -133.20M | -151.08M | -88.44M | -16.12M | -6.72M |
| Depreciation & Amortization | 2.14M | 2.27M | 1.98M | 839.00K | 356.00K | 91.00K |
| Stock-Based Compensation | 24.98M | 31.14M | 26.21M | 3.75M | 113.00K | 30.00K |
| Other Working Capital | 10.02M | 2.15M | 1.57M | 3.65M | -440.00K | 118.00K |
| Other Non-Cash Items | 1.10M | 2.69M | 2.59M | 39.15M | 294.00K | 69.00K |
| Deferred Income Tax | - | - | 4.00M | 326.00K | -4.00K | - |
| Change in Working Capital | 5.88M | 6.18M | -1.62M | 6.46M | 276.00K | 90.00K |
| Operating Cash Flow | -78.58M | -90.93M | -117.92M | -37.91M | -15.08M | -6.44M |
| Capital Expenditures | -679.00K | -577.00K | -4.26M | -9.57M | -2.95M | -1.07M |
| Acquisitions | - | 31.64M | -67.98M | 150.67M | - | - |
| Purchase of Investments | -212.96M | -367.12M | -177.73M | -229.33M | -64.63M | - |
| Sales Maturities Of Investments | 280.00M | 335.48M | 245.72M | 78.66M | - | - |
| Other Investing Acitivies | -1 | -31.64M | 67.98M | -150.67M | -64.63M | - |
| Investing Cash Flow | 66.37M | -32.22M | 63.72M | -160.24M | -67.58M | -1.07M |
| Debt Repayment | - | - | -5.00K | 151.24M | -30.00K | -72.00K |
| Common Stock Repurchased | 538.00K | 380.00K | 1.34M | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | 567.00K | 851.00K | 4.46M | 264.37M | 105.04M | 16.29M |
| Financial Cash Flow | 567.00K | 851.00K | 4.46M | 415.61M | 105.01M | 16.22M |
| Net Cash Flow | -11.65M | -122.30M | -49.74M | 217.47M | 22.34M | 8.70M |
| Free Cash Flow | -79.26M | -91.50M | -122.18M | -47.48M | -18.03M | -7.52M |